Concerns have been raised by senior doctors surrounding the misuse of weight-loss pens in the UK, with some patients reporting extreme side effects. | ITV National News ...

Exenatide is a GLP-1 agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus.

Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.

Amneal Pharmaceuticals has submitted another new drug application (NDA) for its dihydroergotamine (DHE) prefilled syringe ...

It’s also the first to be administered using a prefilled pen or syringe. Hympavzi was recently approved in the U.S., where it’s expected to be available by prescription before the end of the year.

Black market weight-loss drugs left a woman thinking she was going to die after do-it-yourself injections put her in hospital ...

Pfizer said the green light makes Hympavzi the first once-weekly subcutaneous treatment in the European Union for people with severe hemophilia B and the first to be administered via a pre-filled pen ...

The investment objective is to provide long-term capital appreciation through investment in a diversified portfolio of securities as defined by a relevant index. To achieve its objective, the Fund ...

The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.

with a new sterile filling line for prefilled syringes (PFS) using isolator technology. Construction of the new line will optimize the design of the Leverkusen facility's manufacturing layout to ...

US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians can combine, mix, or adjust the ingredients of a medication — to meet ...